Interview: Mario Sturion – General Manager, Janssen Mexico
Mario Sturion, the recently appointed general manager of Janssen Mexico, assesses the specific challenges and…
Janssen, the pharmaceutical company of Johnson & Johnson, focuses on some of the most devastating diseases and the most complex medical challenges of our time, across the following five therapeutic areas: Cardiovascular and Metabolism, Neuroscience, Immunology, Oncology and hematology, and Infectious Diseases and Vaccines.
Janssen employs nearly 40,000 people in more than 150 countries around the world. We work to bring innovative treatments for serious unmet medical needs. They are currently ranked as the eighth pharmaceutical company in Mexico, and have ambitions to be within the top five within the next few years.
Contact Details
Miguel Angel de Quévedo 247, Col. Romero de Terreros, C.P. 04310, México, D.F.
Tel. (+52) 555484-2300
https://www.janssen.com.mx
Mario Sturion, the recently appointed general manager of Janssen Mexico, assesses the specific challenges and…
Eric Alvarez, managing director of Janssen Mexico, explains why it is important to distinguish between the public…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years,…
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from…
Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19…
The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for…
Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe,…
Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to…
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of…
As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the…
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…
DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented…
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive,…
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
hystrix medical is an online contracting marketplace for medical devices and replenishing/repeat purchase products…
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the…
Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of…
In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug…
AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office…
The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing…
Sanofi CEO Paul Hudson ignited a heated debate around vaccine nationalism earlier this year when he suggested that…
Genald Senior, general manager for Leterago, the leading pharma distributor in the Dominican Republic, discusses…
Professor Susan M. Gasser, now director and group leader emeritus of the Friedrich Miescher Institute for…
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug…
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020…
From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm…
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems:…
Writing in the March edition of DIA’s Global Forum magazine, EMD Serono’s Ana Padua outlines the findings…
Ipsen CEO David Loew took aim at the lip service often paid to the notion of ‘patient-centricity’ in pharma in…
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare…
In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association…
Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as…
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating…
AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the…
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark,…
Alan Knox of Primex Pharmaceuticals explains how the COVID-19 pandemic has thrust the anaesthesia field back into…
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting…
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual…
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…
Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to…
RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine…
Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation,…
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…
In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused…
Andrew Frye of medtech giant Baxter outlines his management strategy for the diverse APAC region, how growth was…
Bandar Reda outlines the evolution of the trading relationship between the UK and the Arab world, the role of the…
Dr Ann Aerts, head of the Novartis Foundation, highlights how the COVID-19 crisis has thrust artificial…
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox…
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19…
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate,…
Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand…
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Bayer’s Michael Levy casts his eye over the implications of the advent of cell and gene therapies on…
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…
Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intelligence, among the top 10 in the world in…
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…
CEO Ellen Cathrine Andersen introduces Norwegian firm Epiguard’s ‘Epishuttle’ technology for transporting…
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player…
The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s…
Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority…
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in…
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector…
Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his…
Epidemiologist John-Arne Røttingen has had a long and distinguished career in both academia and industry,…
The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in…
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five…
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…
Nerum Pharmaceuticals, a Switzerland-based start-up, is supplying high-grade cannabis products to nine countries…
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation…
On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…
Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to…
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech…
Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences…
Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the…
PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in…
While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Alfasigma Switzerland’s Dr Tytus Litynski introduces the Italian firm’s diversified portfolio of both Rx drugs…
With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head…
Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers…
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…
With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been…
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
Dr Johan Van Hoof, global therapeutic area head of vaccines for Janssen, shares his extensive career experience in…
Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…
Stephen J. Ubl, president and CEO of PhRMA, outlines the unprecedented collaboration and speed with which the…
The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance…
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
COVID-19 has necessitated enormous shifts in the way we live, work, and communicate with each other. Nowhere is…
Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical…
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the…
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their…
Dr Philipp Diesinger and Dr Gabriell Máté outline why a data-driven approach can help optimise patient copay…
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…
Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s…
After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the…
Many countries have struggled to adapt to the shift to remote working and digital communication brought about by…
Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic…
Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the…
Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access,…
Janssen Norway’s Mario Klesse shares his first impressions of the Norwegian pharma market, his strategic…
Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how…
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC…
Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique…
Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s…
Redalpine Venture Partners’ Dr Michael Sidler highlights some of the key trends in the European biotech VC…
AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value…
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare…
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches,…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by…
Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations…
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical…
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the…
Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and…
Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom…
Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative…
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company…
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…
During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger…
On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its…
Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression…
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to…
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing.…
Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational…
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory…
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national…
Dan Schneider discusses the continuing Norwegian identity of Photocure, despite its increasingly global footprint,…
Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in…
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…
Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T…
COVID-19 has drawn global attention to the sorry state of funding and R&D investment in vaccine development and…
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding…
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…
Merck Healthcare’s newly appointed Global Head of Business innovation, Renée C. Amundsen, highlights the…
Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and…
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for…
Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s…
After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even…
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…
Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the…
While Switzerland has Europe’s second-highest proportion of women in the workforce, it trails global…
Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated…
Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his excitement at bringing…
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of…
Rubens Hannun, president of the Arab Brazilian Chamber of Commerce, discusses the commercial relationship between…
Professor Nicolaus Kröger, president of the European Society for Blood and Marrow Transplantation (EBMT)…
Pfizer Switzerland’s Sabine Bruckner discusses Switzerland’s historic and continuing importance to Pfizer,…
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the…
Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy…
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines.…
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug…
A roundup of the latest from Chinese pharma, including Green Valley’s upcoming US trial for an…
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
John-Arne Røttingen, CEO of The Research Council of Norway shares his career journey from academia to industry,…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
In his latest piece on Alzheimer’s Disease (AD) drug Aducanumab’s winding journey to market, Dr Neil Cashman…
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard…
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…
CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey,…
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…